<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Creatine and Strength: Systematic Review of Performance Outcomes</title>
  <meta name="description" content="Systematic review of creatine&#39;s effects on muscular strength. Analysis of 1RM improvements, upper vs lower body gains, trained vs untrained populations,...">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://creatineresearch.co/science/creatine-and-strength-gains">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://creatineresearch.co/science/creatine-and-strength-gains">
  <meta property="og:title" content="Creatine and Strength: Systematic Review of Performance Outcomes">
  <meta property="og:description" content="Systematic review of creatine&#39;s effects on muscular strength. Analysis of 1RM improvements, upper vs lower body gains, trained vs untrained populations,...">
  <meta property="og:site_name" content="Creatine Research">
  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:title" content="Creatine and Strength: Systematic Review of Performance Outcomes">
  <meta name="twitter:description" content="Systematic review of creatine&#39;s effects on muscular strength. Analysis of 1RM improvements, upper vs lower body gains, trained vs untrained populations,...">
  <script type="application/ld+json">
  {
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What is the foundational meta-analyses?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Rawson and Volek published one of the most cited reviews on creatine and strength in 2003 in the Journal of Strength and Conditioning Research. Their analysis of 22 studies found that creatine supplementation increased maximal strength (defined as 1RM or maximal voluntary contraction) by an average of 8% more than placebo, while training-induced strength gains were amplified by 14% with creatine supplementation. The effect was observed across both upper and lower body exercises, though the magnitude varied between muscle groups and testing methods."
      }
    },
    {
      "@type": "Question",
      "name": "What is the 1rm improvements?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The one-repetition maximum is the gold-standard measure of maximal dynamic strength. Across the published literature, creatine supplementation during resistance training has been shown to increase 1RM bench press by approximately 5 to 10% and 1RM squat by approximately 5 to 15% beyond placebo over 4 to 12 week training periods."
      }
    },
    {
      "@type": "Question",
      "name": "How does upper body vs. lower body compare?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The literature suggests that creatine's strength benefits may differ somewhat between upper and lower body musculature, though the direction of this difference has been debated."
      }
    },
    {
      "@type": "Question",
      "name": "How does trained vs. untrained populations compare?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The interaction between training status and creatine responsiveness is important for both researchers and practitioners. Untrained individuals beginning a resistance program experience rapid strength gains due to neural adaptations, motor learning, and initial hypertrophy. Adding creatine to this already-steep improvement curve produces measurable additional gains."
      }
    },
    {
      "@type": "Question",
      "name": "What is the mechanisms of strength enhancement?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Creatine's effects on strength operate through several interconnected mechanisms."
      }
    }
  ]
}
  </script>

  <link rel="icon" type="image/svg+xml" href="data:image/svg+xml,<svg xmlns='http://www.w3.org/2000/svg' viewBox='0 0 100 100'><rect fill='%230f172a' width='100' height='100' rx='12'/><text x='50' y='68' font-family='monospace' font-size='40' fill='%230284c7' text-anchor='middle'>Cr</text></svg>">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=DM+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
  <script src="https://cdn.tailwindcss.com"></script>
  <script>
    tailwind.config = {
      darkMode: 'class',
      theme: {
        extend: {
          fontFamily: {
            sans: ['DM Sans', 'system-ui', 'sans-serif'],
            serif: ['Instrument Serif', 'Georgia', 'serif'],
          },
          colors: {
            slate: { 925: '#0c0f14', 950: '#090b10' }
          }
        }
      }
    }
  </script>
  <style>
    ::selection { background: rgba(2, 132, 199, 0.3); }
    ::-webkit-scrollbar { width: 8px; }
    ::-webkit-scrollbar-track { background: var(--bg-secondary, #18181b); }
    ::-webkit-scrollbar-thumb { background: var(--border, #27272a); border-radius: 4px; }
    ::-webkit-scrollbar-thumb:hover { background: #3f3f46; }

    /* Article body — light mode */
    .article-body { max-width: 720px; margin: 0 auto; padding: 0 1rem; }
    .article-body h1 { font-family: 'Instrument Serif', Georgia, serif; font-size: 2.75rem; line-height: 1.15; margin-bottom: 1rem; color: #0f172a; }
    .article-body h2 { font-family: 'Instrument Serif', Georgia, serif; font-size: 1.875rem; margin: 2.5rem 0 1rem; color: #0f172a; }
    .article-body h3 { font-size: 1.25rem; font-weight: 600; margin: 2rem 0 0.75rem; color: #0f172a; }
    .article-body p { margin-bottom: 1.5rem; color: #475569; line-height: 1.8; }
    .article-body a { color: #0284c7; text-decoration: none; }
    .article-body a:hover { text-decoration: underline; }
    .article-body ul, .article-body ol { margin: 1.5rem 0; padding-left: 1.5rem; color: #475569; }
    .article-body li { margin-bottom: 0.75rem; line-height: 1.7; }
    .article-body strong { color: #1e293b; }
    .article-body blockquote { border-left: 3px solid #0284c7; padding-left: 1.5rem; margin: 2rem 0; font-style: italic; color: #334155; }
    .article-body .meta { color: #64748b; font-size: 0.9rem; margin-bottom: 2rem; }
    .article-body table { width: 100%; border-collapse: collapse; margin: 2rem 0; }
    .article-body th, .article-body td { text-align: left; padding: 0.75rem 1rem; border-bottom: 1px solid #e2e8f0; color: #475569; }
    .article-body th { color: #0f172a; font-weight: 600; border-bottom: 2px solid #cbd5e1; }
    .article-body .cta-box {
      background: linear-gradient(135deg, rgba(2, 132, 199, 0.08), rgba(13, 148, 136, 0.04));
      border: 1px solid rgba(2, 132, 199, 0.2);
      border-radius: 16px; padding: 2.5rem; margin: 3rem 0; text-align: center;
    }
    .article-body .cta-box h3 { margin-top: 0; font-family: 'Instrument Serif', Georgia, serif; font-size: 1.5rem; }
    .article-body .cta-box p { color: #64748b; margin-bottom: 1.5rem; }
    .article-body .cta-button {
      display: inline-block; background: #0284c7; color: #ffffff;
      padding: 1rem 2rem; border-radius: 8px; font-weight: 600;
      text-decoration: none; transition: background 0.2s;
    }
    .article-body .cta-button:hover { background: #0ea5e9; text-decoration: none; }
    .article-body .related-articles { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .related-articles h3 { margin-bottom: 1rem; }
    .article-body .related-articles ul { list-style: none; padding: 0; }
    .article-body .related-articles li { margin-bottom: 0.5rem; }
    .article-body .faq-section { margin-top: 3rem; padding-top: 2rem; border-top: 1px solid #e2e8f0; }
    .article-body .faq-section > h2 { margin-top: 0; }
    .article-body .faq-item { margin-bottom: 2rem; }
    .article-body .faq-item h3 { color: #0f172a; margin-bottom: 0.5rem; }
    .article-body .faq-item p { margin-bottom: 0; }

    /* Article body — dark mode */
    .dark .article-body h1, .dark .article-body h2, .dark .article-body h3 { color: #fafaf9; }
    .dark .article-body p { color: #a1a1aa; }
    .dark .article-body ul, .dark .article-body ol { color: #a1a1aa; }
    .dark .article-body strong { color: #e4e4e7; }
    .dark .article-body a { color: #38bdf8; }
    .dark .article-body blockquote { color: #d4d4d8; }
    .dark .article-body .meta { color: #71717a; }
    .dark .article-body th, .dark .article-body td { border-bottom-color: #27272a; color: #a1a1aa; }
    .dark .article-body th { color: #fafaf9; border-bottom-color: #3f3f46; }
    .dark .article-body .cta-box { background: linear-gradient(135deg, rgba(2, 132, 199, 0.12), rgba(13, 148, 136, 0.06)); }
    .dark .article-body .cta-box p { color: #a1a1aa; }
    .dark .article-body .related-articles { border-top-color: #27272a; }
    .dark .article-body .faq-section { border-top-color: #27272a; }
    .dark .article-body .faq-item h3 { color: #fafaf9; }

    /* Newsletter section */
    #newsletter input::placeholder { color: #94a3b8; }
    .dark #newsletter input::placeholder { color: #52525b; }


    /* Mega menu */
    .mega-panel { transition: opacity 0.15s ease, visibility 0.15s ease; }
    .mega-panel.hidden { opacity: 0; visibility: hidden; display: none; }
    .mega-panel:not(.hidden) { opacity: 1; visibility: visible; display: block; }
    .mega-link {
      display: block; padding: 6px 0;
      font-size: 0.875rem; color: #475569;
      transition: color 0.15s;
    }
    .mega-link:hover { color: #0f172a; text-decoration: none; }
    .dark .mega-link { color: #a1a1aa; }
    .dark .mega-link:hover { color: #fafaf9; }
    .mega-view-all {
      display: inline-block; margin-top: 12px;
      font-size: 0.8125rem; font-weight: 500;
      color: #0284c7; transition: color 0.15s;
    }
    .mega-view-all:hover { color: #0ea5e9; text-decoration: none; }
    .dark .mega-view-all { color: #38bdf8; }
    .dark .mega-view-all:hover { color: #7dd3fc; }

    /* Nav effects */
    .nav-link { position: relative; }
    .nav-link::after {
      content: ''; position: absolute; bottom: -2px; left: 0;
      width: 0; height: 1px; background: #0284c7; transition: width 0.3s ease;
    }
    .nav-link:hover::after { width: 100%; }
    .cta-glow { position: relative; }
    .cta-glow::before {
      content: ''; position: absolute; inset: -2px;
      background: linear-gradient(135deg, #0284c7, #0891b2);
      border-radius: inherit; opacity: 0; filter: blur(12px);
      transition: opacity 0.3s ease; z-index: -1;
    }
    .cta-glow:hover::before { opacity: 0.4; }

    /* Active trigger state */
    .mega-trigger[aria-expanded="true"] { color: #0f172a; }
    .dark .mega-trigger[aria-expanded="true"] { color: #fafaf9; }
    .mega-trigger[aria-expanded="true"] svg { transform: rotate(180deg); }


    @media (max-width: 768px) {
      .article-body h1 { font-size: 2rem; }
      .article-body h2 { font-size: 1.5rem; }
    }
  </style>
</head>
<body class="bg-slate-50 dark:bg-slate-950 font-sans antialiased">

  <nav class="fixed top-0 left-0 right-0 z-50 border-b border-slate-200 dark:border-zinc-800/60 bg-white/90 dark:bg-slate-950/90 backdrop-blur-md">
    <div class="max-w-7xl mx-auto">
      <div class="flex items-center justify-between h-16 px-6">
        <!-- Logo -->
        <a href="/" class="flex items-center gap-3 group">
          <div class="w-8 h-8 rounded-md bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center group-hover:border-sky-500/50 transition-colors">
            <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
          </div>
          <span class="text-slate-500 dark:text-zinc-400 text-sm tracking-tight">
            <span class="text-slate-800 dark:text-zinc-200 font-medium">Creatine</span><span class="text-sky-600 dark:text-sky-400">Research</span>
          </span>
        </a>

        <!-- Desktop Nav -->
        <div class="hidden lg:flex items-center gap-1">

          <!-- Science dropdown -->
          <div class="relative" data-mega="science">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Research
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- Applications dropdown -->
          <div class="relative" data-mega="applications">
            <button class="mega-trigger nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors flex items-center gap-1">
              Applications
              <svg class="w-3 h-3 opacity-50 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
            </button>
          </div>

          <!-- All Articles link -->
          <a href="/articles" class="nav-link px-4 py-2 text-sm text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200 transition-colors">All Articles</a>

          <div class="w-px h-4 bg-slate-300 dark:bg-zinc-800 mx-2"></div>

          <!-- CTA -->
          <a href="#newsletter" class="px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors cta-glow">Research Updates</a>
        </div>

        <!-- Mobile menu button -->
        <button id="mobile-menu-btn" class="lg:hidden p-2 text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-zinc-200">
          <svg id="menu-icon" class="w-5 h-5" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
          <svg id="close-icon" class="w-5 h-5 hidden" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M6 18L18 6M6 6l12 12"></path></svg>
        </button>
      </div>

      <!-- ═══ MEGA PANEL: Research ═══ -->
      <div id="mega-science" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-3 gap-8">
            <!-- Column 1: Science -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Science & Mechanisms</span>
              </div>
              <div class="space-y-1">
                <a href="/science/what-is-creatine-monohydrate" class="mega-link">What Is Creatine Monohydrate?</a>
                <a href="/science/how-creatine-works-in-the-body" class="mega-link">How Creatine Works</a>
                <a href="/science/creatine-atp-resynthesis" class="mega-link">ATP Resynthesis</a>
                <a href="/science/creatine-and-muscle-growth" class="mega-link">Muscle Growth Research</a>
                <a href="/science/creatine-and-brain-function" class="mega-link">Brain Function</a>
                <a href="/science/creatine-and-aging" class="mega-link">Aging & Sarcopenia</a>
              </div>
              <a href="/science" class="mega-view-all">All 20 articles &rarr;</a>
            </div>

            <!-- Column 2: Dosing & Safety -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-teal-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12h6m-6 4h6m2 5H7a2 2 0 01-2-2V5a2 2 0 012-2h5.586a1 1 0 01.707.293l5.414 5.414a1 1 0 01.293.707V19a2 2 0 01-2 2z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Dosing & Safety</span>
              </div>
              <div class="space-y-1">
                <a href="/dosing/creatine-loading-protocol" class="mega-link">Loading Protocol</a>
                <a href="/dosing/creatine-maintenance-dose" class="mega-link">Maintenance Dosing</a>
                <a href="/dosing/creatine-timing-before-or-after-workout" class="mega-link">Timing: Before or After?</a>
                <a href="/safety/is-creatine-safe" class="mega-link">Is Creatine Safe?</a>
                <a href="/safety/creatine-and-kidneys" class="mega-link">Kidney Health</a>
                <a href="/safety/creatine-and-hair-loss" class="mega-link">Hair Loss Myth</a>
              </div>
              <a href="/dosing" class="mega-view-all">Dosing (15) &rarr;</a>
              <span class="mx-2 text-slate-300 dark:text-zinc-700">|</span>
              <a href="/safety" class="mega-view-all">Safety (15) &rarr;</a>
            </div>

            <!-- Column 3: CTA Card -->
            <div class="bg-gradient-to-br from-sky-500/10 to-teal-500/5 dark:from-sky-500/15 dark:to-teal-500/5 border border-sky-500/20 rounded-xl p-6 flex flex-col justify-between">
              <div>
                <h3 class="text-lg font-semibold text-slate-900 dark:text-zinc-100 mb-2">Evidence-Based Research</h3>
                <p class="text-sm text-slate-600 dark:text-zinc-400 mb-4">Every article cites peer-reviewed studies. No marketing hype. Just what the science shows.</p>
              </div>
              <a href="/science/creatine-mechanisms-summary" class="inline-flex items-center justify-center px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg text-sm transition-colors cta-glow">
                Complete Research Guide
              </a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ MEGA PANEL: Applications ═══ -->
      <div id="mega-applications" class="mega-panel hidden border-t border-slate-200 dark:border-zinc-800/60 bg-white dark:bg-slate-950">
        <div class="max-w-7xl mx-auto px-6 py-8">
          <div class="grid grid-cols-4 gap-8">
            <!-- Column 1: By Sport -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-amber-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 10V3L4 14h7v7l9-11h-7z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">By Sport</span>
              </div>
              <div class="space-y-1">
                <a href="/sports/creatine-for-powerlifting" class="mega-link">Powerlifting</a>
                <a href="/sports/creatine-for-bodybuilding" class="mega-link">Bodybuilding</a>
                <a href="/sports/creatine-for-crossfit" class="mega-link">CrossFit</a>
                <a href="/sports/creatine-for-mma" class="mega-link">MMA & Combat Sports</a>
                <a href="/sports/creatine-for-soccer" class="mega-link">Soccer</a>
                <a href="/sports/creatine-for-swimming" class="mega-link">Swimming</a>
              </div>
              <a href="/sports" class="mega-view-all">All 20 sports &rarr;</a>
            </div>

            <!-- Column 2: Comparisons -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-violet-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M8 7h12m0 0l-4-4m4 4l-4 4m0 6H4m0 0l4 4m-4-4l4-4"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">vs Other Supplements</span>
              </div>
              <div class="space-y-1">
                <a href="/comparisons/creatine-vs-protein-powder" class="mega-link">vs Protein Powder</a>
                <a href="/comparisons/creatine-vs-bcaa" class="mega-link">vs BCAAs</a>
                <a href="/comparisons/creatine-vs-beta-alanine" class="mega-link">vs Beta-Alanine</a>
                <a href="/comparisons/creatine-vs-pre-workout" class="mega-link">vs Pre-Workout</a>
                <a href="/comparisons/creatine-vs-ashwagandha" class="mega-link">vs Ashwagandha</a>
              </div>
              <a href="/comparisons" class="mega-view-all">All 15 comparisons &rarr;</a>
            </div>

            <!-- Column 3: Product Quality -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-emerald-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m5.618-4.016A11.955 11.955 0 0112 2.944a11.955 11.955 0 01-8.618 3.04A12.02 12.02 0 003 9c0 5.591 3.824 10.29 9 11.622 5.176-1.332 9-6.03 9-11.622 0-1.042-.133-2.052-.382-3.016z"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Product Quality</span>
              </div>
              <div class="space-y-1">
                <a href="/quality/creatine-monohydrate-vs-hcl" class="mega-link">Monohydrate vs HCl</a>
                <a href="/quality/creatine-forms-comparison" class="mega-link">All Forms Compared</a>
                <a href="/quality/third-party-testing-creatine" class="mega-link">Third-Party Testing</a>
                <a href="/quality/creapure-vs-generic-creatine" class="mega-link">Creapure vs Generic</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/quality" class="mega-view-all">All 15 guides &rarr;</a>
            </div>

            <!-- Column 4: Quick Links -->
            <div>
              <div class="flex items-center gap-2 mb-4">
                <svg class="w-4 h-4 text-sky-500" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 7h8m0 0v8m0-8l-8 8-4-4-6 6"></path></svg>
                <span class="text-xs font-semibold tracking-wider text-slate-500 dark:text-zinc-500 uppercase">Quick Links</span>
              </div>
              <div class="space-y-1">
                <a href="/science/creatine-mechanisms-summary" class="mega-link">Complete Science Guide</a>
                <a href="/dosing/creatine-dosing-protocols-summary" class="mega-link">Complete Dosing Guide</a>
                <a href="/safety/creatine-safety-complete-guide" class="mega-link">Complete Safety Guide</a>
                <a href="/sports/creatine-for-sport-summary" class="mega-link">Every Sport Guide</a>
                <a href="/quality/creatine-buying-guide" class="mega-link">Buying Guide</a>
              </div>
              <a href="/articles" class="mega-view-all">All 100 articles &rarr;</a>
            </div>
          </div>
        </div>
      </div>

      <!-- ═══ Mobile Menu ═══ -->
      <div id="mobile-menu" class="hidden lg:hidden border-t border-slate-200 dark:border-zinc-800 bg-white dark:bg-slate-950 max-h-[80vh] overflow-y-auto">
        <div class="px-6 py-4 space-y-1">
          <!-- Research -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Research
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Science</p>
            <a href="/science/what-is-creatine-monohydrate" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">What Is Creatine?</a>
            <a href="/science/how-creatine-works-in-the-body" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">How Creatine Works</a>
            <a href="/science" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Dosing</p>
            <a href="/dosing/creatine-loading-protocol" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Loading Protocol</a>
            <a href="/dosing/creatine-maintenance-dose" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Maintenance Dose</a>
            <a href="/dosing" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Safety</p>
            <a href="/safety/is-creatine-safe" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Is Creatine Safe?</a>
            <a href="/safety/creatine-and-kidneys" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Kidney Health</a>
            <a href="/safety" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 articles &rarr;</a>
          </div>

          <!-- Applications -->
          <button class="mobile-section-toggle w-full flex items-center justify-between py-3 text-slate-800 dark:text-zinc-200 font-medium">
            Applications
            <svg class="w-4 h-4 text-slate-400 dark:text-zinc-600 transition-transform" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19 9l-7 7-7-7"></path></svg>
          </button>
          <div class="mobile-section hidden pl-4 pb-3 space-y-1">
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-1 pb-1">Sports</p>
            <a href="/sports/creatine-for-powerlifting" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Powerlifting</a>
            <a href="/sports/creatine-for-bodybuilding" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">Bodybuilding</a>
            <a href="/sports" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 20 sports &rarr;</a>
            <p class="text-xs text-slate-400 dark:text-zinc-600 uppercase tracking-wider pt-3 pb-1">Comparisons</p>
            <a href="/comparisons/creatine-vs-protein-powder" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs Protein Powder</a>
            <a href="/comparisons/creatine-vs-bcaa" class="block py-1.5 text-sm text-slate-600 dark:text-zinc-400 hover:text-slate-900 dark:hover:text-white">vs BCAAs</a>
            <a href="/comparisons" class="block py-1.5 text-sm text-sky-600 dark:text-sky-400 font-medium">All 15 comparisons &rarr;</a>
          </div>

          <!-- Direct links -->
          <a href="/articles" class="block py-3 text-slate-800 dark:text-zinc-200 font-medium">All Articles</a>

          <!-- CTA -->
          <a href="#newsletter" class="block mt-4 py-3 bg-sky-600 text-white text-center font-semibold rounded-lg">Get Research Updates</a>
        </div>
      </div>
    </div>
  </nav>

  <main class="pt-24 pb-16">
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mb-6">
      <div class="flex items-center gap-2 text-sm">
        <a href="/" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Home</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/articles" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Articles</a>
        <span class="text-slate-300 dark:text-zinc-700">/</span>
        <a href="/science" class="text-slate-400 dark:text-zinc-600 hover:text-slate-600 dark:hover:text-zinc-400 transition-colors">Science & Mechanisms</a>
      </div>
    </div>
    <div class="article-body">
      <article>
    <h1>Creatine and Strength: Systematic Review of Performance Outcomes</h1>

    <p>Strength is the primary functional outcome most athletes seek from creatine supplementation, and it is also the outcome with the deepest evidence base. Since the early 1990s, hundreds of controlled trials have measured creatine's effect on various strength parameters, from one-repetition maximum (1RM) in compound lifts to isokinetic peak torque and maximal voluntary contraction. Systematic reviews and meta-analyses have synthesized this literature into clear, quantitative conclusions. This article examines those findings across populations, muscle groups, and dosing strategies.</p>

    <h2>The Foundational Meta-Analyses</h2>

    <p>Rawson and Volek published one of the most cited reviews on creatine and strength in 2003 in the Journal of Strength and Conditioning Research. Their analysis of 22 studies found that creatine supplementation increased maximal strength (defined as 1RM or maximal voluntary contraction) by an average of 8% more than placebo, while training-induced strength gains were amplified by 14% with creatine supplementation. The effect was observed across both upper and lower body exercises, though the magnitude varied between muscle groups and testing methods.</p>

    <p>Branch's 2003 meta-analysis, which examined 100 comparisons across multiple studies, corroborated these findings. The analysis stratified outcomes by exercise type and found weighted mean effect sizes (Cohen's d) of 0.24 for maximal strength measures and 0.26 for weightlifting performance. These are small to moderate effect sizes by conventional standards, but in the context of sports performance where margins are measured in single-digit percentages, they represent practically significant differences.</p>

    <p>A more recent meta-analysis by Lanhers and colleagues in 2017, published in Sports Medicine, updated the evidence and found that creatine supplementation increased upper body strength by a weighted mean difference of approximately 5.3% and lower body strength by approximately 5.3% as well, relative to placebo. The effect was statistically robust and consistent across the sensitivity analyses performed.</p>

    <h2>1RM Improvements: What the Numbers Show</h2>

    <p>The one-repetition maximum is the gold-standard measure of maximal dynamic strength. Across the published literature, creatine supplementation during resistance training has been shown to increase 1RM bench press by approximately 5 to 10% and 1RM squat by approximately 5 to 15% beyond placebo over 4 to 12 week training periods.</p>

    <p>Volek and colleagues in 1999 reported that subjects supplementing with creatine during 12 weeks of periodized resistance training increased their 1RM bench press by 24% compared to 16% in the placebo group, and their 1RM squat by 32% compared to 24% in the placebo group. While these absolute numbers reflect untrained participants beginning a resistance program, the differential between creatine and placebo was consistent and statistically significant.</p>

    <p>Pearson and colleagues in 1999 examined trained individuals and found that creatine supplementation for 10 weeks produced greater 1RM improvements in both bench press and squat compared to placebo. The creatine group increased squat 1RM by approximately 6% more than the placebo group, representing a meaningful advantage for individuals already adapted to resistance training.</p>

    <p>The mechanism underlying these 1RM improvements is multifactorial. Acutely, elevated phosphocreatine stores allow for faster ATP regeneration during maximal efforts. Chronically, creatine enables higher training volumes during progressive overload programs, meaning the creatine user accumulates more total mechanical tension over a training block. Both acute and chronic pathways converge to produce greater maximal strength outcomes.</p>

    <h2>Upper Body vs. Lower Body: Differential Effects</h2>

    <p>The literature suggests that creatine's strength benefits may differ somewhat between upper and lower body musculature, though the direction of this difference has been debated.</p>

    <p>Rawson and Volek's 2003 review found that upper body strength measures showed a slightly larger response to creatine supplementation than lower body measures. They hypothesized that this might relate to muscle fiber type distribution, since upper body musculature tends to have a higher proportion of Type II (fast-twitch) fibers, which are more dependent on the phosphocreatine system for rapid energy production. Greater reliance on phosphocreatine during maximal upper body efforts would logically produce a larger benefit from supplementation.</p>

    <p>However, Branch's meta-analysis found relatively similar effect sizes between upper and lower body exercises. More recent data have not resolved this discrepancy definitively. Part of the inconsistency may stem from methodological differences in how lower body strength is assessed. Leg press, squat, and knee extension all test lower body strength, but the bioenergetic demands and muscle recruitment patterns differ substantially between these movements.</p>

    <p>The practical takeaway is that creatine augments strength across all major muscle groups. Whether upper body benefits are marginally larger than lower body benefits remains an open empirical question, but the difference, if it exists, is small relative to the overall positive effect observed in both regions.</p>

    <h2>Trained vs. Untrained Populations</h2>

    <p>The interaction between training status and creatine responsiveness is important for both researchers and practitioners. Untrained individuals beginning a resistance program experience rapid strength gains due to neural adaptations, motor learning, and initial hypertrophy. Adding creatine to this already-steep improvement curve produces measurable additional gains.</p>

    <p>Rawson and Volek found that the absolute magnitude of creatine-induced strength improvement was larger in untrained individuals than in trained individuals when expressed as a percentage of baseline. This is not surprising, given that untrained individuals have more room for improvement and are further from their genetic ceiling. However, trained individuals also showed significant strength increases with creatine, and the relative benefit as a percentage of the training-induced gain was comparable between populations.</p>

    <p>Kreider and colleagues, in the 2017 International Society of Sports Nutrition position stand on creatine, noted that trained athletes supplementing with creatine typically see 5 to 10% greater improvements in maximal strength compared to training with placebo. For an athlete already squatting 180 kg, an additional 5% represents 9 kg, which is a substantial competitive advantage.</p>

    <p>Buford and colleagues in 2007 published a position stand through the International Society of Sports Nutrition that specifically addressed the trained population, concluding that creatine was the most effective ergogenic supplement available for increasing high-intensity exercise capacity and lean body mass during training. This conclusion was based on the consistency of positive findings across studies using trained subjects.</p>

    <h2>Mechanisms of Strength Enhancement</h2>

    <p>Creatine's effects on strength operate through several interconnected mechanisms.</p>

    <p>The most direct mechanism is enhanced phosphocreatine availability. During a maximal effort lasting 5 to 15 seconds, the phosphocreatine system provides the majority of ATP. Higher intramuscular phosphocreatine concentrations allow for faster and more sustained ATP regeneration during these efforts. This translates directly to greater force production capacity during 1RM attempts and during the later repetitions of high-intensity sets.</p>

    <p>The second mechanism is improved training quality. Because creatine allows athletes to perform more repetitions at a given intensity or maintain higher intensities across sets, the total training stimulus accumulated over weeks is greater in creatine-supplemented individuals. Strength is an adaptation to progressive mechanical overload. Any intervention that allows for greater overload accumulation will, given adequate recovery, produce greater strength gains.</p>

    <p>Casey and Greenhaff published data in 2000 showing that creatine supplementation increased the resynthesis rate of phosphocreatine during recovery between sets. This means creatine users recover faster between high-intensity efforts, maintaining performance quality throughout a training session. The downstream consequence is more productive training and, therefore, greater strength adaptation over time.</p>

    <p>A third mechanism involves the interaction between increased lean mass and strength. As discussed elsewhere in this series, creatine augments lean mass gains from resistance training. Increased muscle cross-sectional area directly contributes to force production capacity. Part of the strength gain observed with creatine supplementation reflects this indirect pathway through enhanced hypertrophy.</p>

    <h2>Dose-Response Relationships</h2>

    <p>The standard creatine dosing protocol involves a loading phase of 20 g per day (typically 4 doses of 5 g) for 5 to 7 days, followed by a maintenance dose of 3 to 5 g per day. The loading phase saturates intramuscular creatine stores, which typically increases total muscle creatine content by 20 to 40%.</p>

    <p>Hultman and colleagues demonstrated in 1996 that the loading protocol raised muscle creatine and phosphocreatine concentrations rapidly and that a maintenance dose of 2 g per day was sufficient to maintain elevated stores over 30 days. However, subsequent work by Rawson and colleagues found that 3 to 5 g per day provided more reliable maintenance across individuals with varying body mass.</p>

    <p>The dose-response relationship for strength outcomes is not strictly linear. Below a threshold of approximately 2 g per day, muscle creatine stores decline toward baseline over several weeks, and any strength benefits would be expected to attenuate. Above 5 g per day during the maintenance phase, there is no evidence of additional benefit, because the muscle creatine transporter system reaches saturation and excess creatine is excreted through the kidneys.</p>

    <p>Loading is not strictly necessary. Chronic supplementation at 3 to 5 g per day without a loading phase achieves full muscle creatine saturation in approximately 3 to 4 weeks. The practical difference is timing. Athletes preparing for a competition or training block who want immediate benefits may prefer loading. Those with a longer time horizon can simply begin with the maintenance dose.</p>

    <p>Body mass should be considered when determining maintenance dose. A 60 kg individual requires less creatine to maintain saturated stores than a 100 kg individual. A rough guideline is 0.03 to 0.05 g per kg of body mass per day during the maintenance phase, though most research has used a flat 5 g per day dose across body sizes without adverse outcomes.</p>

    <h2>Repetition Performance and Work Capacity</h2>

    <p>Beyond maximal strength, creatine also enhances the ability to perform repeated high-intensity efforts. Multiple studies have shown that creatine supplementation increases the number of repetitions completed at a fixed percentage of 1RM, increases total work performed across multiple sets, and reduces performance decrements during repeated sprint protocols.</p>

    <p>Arciero and colleagues in 2001 found that creatine supplementation increased the number of bench press repetitions performed at 70% of 1RM by approximately 26% compared to placebo. Noonan and colleagues in 1998 similarly reported increased total work during multiple sets of bench press and leg press.</p>

    <p>This enhanced work capacity has cascading effects on strength development. A trainee who can complete 10 repetitions instead of 8 at a given load accumulates more mechanical tension per set. Over a training program spanning weeks or months, this difference in per-session training volume compounds into meaningfully greater strength adaptation.</p>

    <h2>Time Course of Strength Effects</h2>

    <p>The time course of creatine's strength effects reflects the underlying mechanisms. Acute performance improvements can be observed within 5 to 7 days of loading, reflecting the immediate bioenergetic advantage of elevated phosphocreatine stores. These acute effects include improved performance on repeated sprint tests, increased repetition performance, and modestly improved 1RM in some studies.</p>

    <p>Chronic strength improvements accumulate over weeks and months as the enhanced training capacity translates into greater neuromuscular and structural adaptation. The largest between-group differences (creatine vs. placebo) in maximal strength typically emerge after 8 to 12 weeks of combined supplementation and progressive training. This is because the cumulative advantage of higher training quality takes time to manifest as measurable strength differences.</p>

    <p>Cessation of creatine supplementation results in a gradual return of muscle creatine stores to baseline over approximately 4 to 6 weeks. Strength gains accrued during the supplementation period are largely maintained, because they reflect structural and neural adaptations rather than acute pharmacological effects. However, the ongoing training quality advantage is lost, meaning the rate of future strength gains may return to pre-supplementation levels.</p>

    <h2>Summary of Strength Evidence</h2>

    <p>The evidence for creatine's effect on muscular strength is extensive and consistent. Meta-analyses report average strength increases of 5 to 10% beyond placebo during resistance training programs, with effects observed in both upper and lower body musculature and across trained and untrained populations. The mechanisms include direct enhancement of the phosphocreatine energy system, improved training quality and work capacity, and indirect effects through augmented lean mass. Dosing follows a well-characterized protocol of optional loading (20 g/day for 5-7 days) followed by maintenance at 3-5 g per day. Creatine monohydrate is the most extensively validated supplement for improving resistance training-induced strength gains in the published literature.</p>

    <section id="bibliography">
      <h2>References</h2>
      <ol>
        <li>Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. <em>Journal of Strength and Conditioning Research</em>. 2003;17(4):822-831. doi:10.1519/1533-4287(2003)017&lt;0822:EOCSAR&gt;2.0.CO;2</li>
        <li>Branch JD. Effect of creatine supplementation on body composition and performance: a meta-analysis. <em>International Journal of Sport Nutrition and Exercise Metabolism</em>. 2003;13(2):198-226. doi:10.1123/ijsnem.13.2.198</li>
        <li>Lanhers C, Pereira B, Naughton G, Trousselard M, Lesage FX, Dutheil F. Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. <em>Sports Medicine</em>. 2017;47(1):163-173. doi:10.1007/s40279-016-0571-4</li>
        <li>Volek JS, Duncan ND, Mazzetti SA, et al. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. <em>Medicine and Science in Sports and Exercise</em>. 1999;31(8):1147-1156. doi:10.1097/00005768-199908000-00011</li>
        <li>Pearson DR, Hamby DG, Russel W, Harris T. Long-term effects of creatine monohydrate on strength and power. <em>Journal of Strength and Conditioning Research</em>. 1999;13(3):187-192.</li>
        <li>Kreider RB, Kalman DS, Antonio J, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. <em>Journal of the International Society of Sports Nutrition</em>. 2017;14:18. doi:10.1186/s12970-017-0173-z</li>
        <li>Buford TW, Kreider RB, Stout JR, et al. International Society of Sports Nutrition position stand: creatine supplementation and exercise. <em>Journal of the International Society of Sports Nutrition</em>. 2007;4:6. doi:10.1186/1550-2783-4-6</li>
        <li>Casey A, Greenhaff PL. Does dietary creatine supplementation play a role in skeletal muscle metabolism and performance? <em>The American Journal of Clinical Nutrition</em>. 2000;72(2 Suppl):607S-617S. doi:10.1093/ajcn/72.2.607S</li>
        <li>Hultman E, Soderlund K, Timmons JA, Cederblad G, Greenhaff PL. Muscle creatine loading in men. <em>Journal of Applied Physiology</em>. 1996;81(1):232-237. doi:10.1152/jappl.1996.81.1.232</li>
        <li>Arciero PJ, Hannibal NS, Nindl BC, Gentile CL, Hamed J, Vukovich MD. Comparison of creatine ingestion and resistance training on energy expenditure and limb blood flow. <em>Metabolism</em>. 2001;50(12):1429-1434. doi:10.1053/meta.2001.28159</li>
        <li>Noonan D, Berg K, Latin RW, Wagner JC, Reimers K. Effects of varying dosages of oral creatine relative to fat free body mass on strength and body composition. <em>Journal of Strength and Conditioning Research</em>. 1998;12(2):104-108.</li>
        <li>Terjung RL, Clarkson P, Eichner ER, et al. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation. <em>Medicine and Science in Sports and Exercise</em>. 2000;32(3):706-717. doi:10.1097/00005768-200003000-00024</li>
      </ol>
    </section>
      
      <section class="faq-section">
        <h2>Frequently Asked Questions</h2>
        
        <div class="faq-item">
          <h3>What is the foundational meta-analyses?</h3>
          <p>Rawson and Volek published one of the most cited reviews on creatine and strength in 2003 in the Journal of Strength and Conditioning Research. Their analysis of 22 studies found that creatine supplementation increased maximal strength (defined as 1RM or maximal voluntary contraction) by an average of 8% more than placebo, while training-induced strength gains were amplified by 14% with creatine supplementation. The effect was observed across both upper and lower body exercises, though the magnitude varied between muscle groups and testing methods.</p>
        </div>
        <div class="faq-item">
          <h3>What is the 1rm improvements?</h3>
          <p>The one-repetition maximum is the gold-standard measure of maximal dynamic strength. Across the published literature, creatine supplementation during resistance training has been shown to increase 1RM bench press by approximately 5 to 10% and 1RM squat by approximately 5 to 15% beyond placebo over 4 to 12 week training periods.</p>
        </div>
        <div class="faq-item">
          <h3>How does upper body vs. lower body compare?</h3>
          <p>The literature suggests that creatine's strength benefits may differ somewhat between upper and lower body musculature, though the direction of this difference has been debated.</p>
        </div>
        <div class="faq-item">
          <h3>How does trained vs. untrained populations compare?</h3>
          <p>The interaction between training status and creatine responsiveness is important for both researchers and practitioners. Untrained individuals beginning a resistance program experience rapid strength gains due to neural adaptations, motor learning, and initial hypertrophy. Adding creatine to this already-steep improvement curve produces measurable additional gains.</p>
        </div>
        <div class="faq-item">
          <h3>What is the mechanisms of strength enhancement?</h3>
          <p>Creatine's effects on strength operate through several interconnected mechanisms.</p>
        </div>
      </section>
      
      </article>

      <!-- In-article CTA -->
      <div class="cta-box">
        <h3>Stay Current on Creatine Research</h3>
        <p>Get evidence-based updates when new studies are published. No hype, no marketing — just what the science shows.</p>
        <a href="#newsletter" class="cta-button">Get Research Updates</a>
      </div>

      <!-- Pillar page link -->
      <div class="related-articles">
        <h3>Read the Full Guide</h3>
        <p style="margin-bottom: 0.75rem;"><a href="/science/creatine-mechanisms-summary">Complete Science Guide: Science & Mechanisms</a> — comprehensive overview with all cited sources.</p>
      </div>
    </div>

    <!-- Category nav -->
    <div class="max-w-3xl mx-auto px-4 sm:px-6 mt-12">
      <div class="flex items-center justify-between p-5 bg-slate-100 dark:bg-zinc-900/50 border border-slate-200 dark:border-zinc-800/60 rounded-xl">
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-1">Category</p>
          <a href="/science" class="text-slate-800 dark:text-zinc-200 font-medium hover:text-sky-600 dark:hover:text-sky-400 transition-colors">Science & Mechanisms</a>
        </div>
        <a href="/science" class="text-sm text-sky-600 dark:text-sky-400 font-medium hover:underline">Browse all &rarr;</a>
      </div>
    </div>
  </main>

  <!-- Newsletter section -->
  <section id="newsletter" class="py-16 bg-slate-100 dark:bg-zinc-900/30 border-t border-slate-200 dark:border-zinc-800/60">
    <div class="max-w-xl mx-auto px-6 text-center">
      <h2 class="font-serif text-3xl text-slate-900 dark:text-zinc-100 mb-3">Research Updates</h2>
      <p class="text-slate-600 dark:text-zinc-400 mb-6">New studies, mechanism breakdowns, and dosing insights — delivered when they matter. No spam. Unsubscribe anytime.</p>
      <form class="flex flex-col sm:flex-row gap-3 justify-center" onsubmit="return false;">
        <input type="email" placeholder="your@email.com" class="px-4 py-3 rounded-lg border border-slate-300 dark:border-zinc-700 bg-white dark:bg-zinc-800 text-slate-900 dark:text-zinc-100 focus:outline-none focus:ring-2 focus:ring-sky-500 w-full sm:w-72">
        <button type="submit" class="px-6 py-3 bg-sky-600 hover:bg-sky-500 text-white font-semibold rounded-lg transition-colors cta-glow">Subscribe</button>
      </form>
      <p class="text-xs text-slate-500 dark:text-zinc-600 mt-3">100% evidence-based. Every claim cited.</p>
    </div>
  </section>


  <footer class="py-16 border-t border-slate-200 dark:border-zinc-900">
    <div class="max-w-7xl mx-auto px-6">
      <div class="grid grid-cols-2 md:grid-cols-6 gap-8 mb-12">
        <div class="col-span-2 md:col-span-2">
          <div class="flex items-center gap-3 mb-3">
            <div class="w-8 h-8 rounded bg-slate-100 dark:bg-zinc-800 border border-slate-200 dark:border-zinc-700 flex items-center justify-center">
              <svg class="w-4 h-4 text-sky-600 dark:text-sky-400" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M19.428 15.428a2 2 0 00-1.022-.547l-2.387-.477a6 6 0 00-3.86.517l-.318.158a6 6 0 01-3.86.517L6.05 15.21a2 2 0 00-1.806.547M8 4h8l-1 1v5.172a2 2 0 00.586 1.414l5 5c1.26 1.26.367 3.414-1.415 3.414H4.828c-1.782 0-2.674-2.154-1.414-3.414l5-5A2 2 0 009 10.172V5L8 4z"></path></svg>
            </div>
            <span class="text-slate-700 dark:text-zinc-300 font-medium">Creatine Research</span>
          </div>
          <p class="text-sm text-slate-600 dark:text-zinc-500 mb-6 max-w-xs">Evidence-based creatine research. Every claim cited. No marketing hype.</p>
          <a href="#newsletter" class="inline-block px-5 py-2 text-sm font-semibold bg-sky-600 hover:bg-sky-500 text-white rounded-md transition-colors">Research Updates</a>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Research</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science</a></li>
            <li><a href="/dosing" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing</a></li>
            <li><a href="/safety" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Applications</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/sports" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">By Sport</a></li>
            <li><a href="/comparisons" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Comparisons</a></li>
            <li><a href="/quality" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Product Quality</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Guides</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/science/creatine-mechanisms-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Science Guide</a></li>
            <li><a href="/dosing/creatine-dosing-protocols-summary" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Dosing Guide</a></li>
            <li><a href="/safety/creatine-safety-complete-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Safety Guide</a></li>
            <li><a href="/quality/creatine-buying-guide" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Buying Guide</a></li>
          </ul>
        </div>
        <div>
          <p class="text-xs text-slate-500 dark:text-zinc-600 uppercase tracking-wider mb-4">Site</p>
          <ul class="space-y-2 text-sm">
            <li><a href="/" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Home</a></li>
            <li><a href="/articles" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">All Articles</a></li>
            <li><a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-slate-900 dark:hover:text-white transition-colors">Scale With Search</a></li>
          </ul>
        </div>
      </div>
      <div class="pt-8 border-t border-slate-200 dark:border-zinc-900 flex flex-col md:flex-row items-center justify-between gap-4">
        <p class="text-xs text-slate-500 dark:text-zinc-700">&copy; 2026 Creatine Research. All cited sources are property of their respective authors.</p>
        <p class="text-xs text-slate-500 dark:text-zinc-700">Powered by <a href="https://scalewithsearch.com" target="_blank" class="text-slate-600 dark:text-zinc-500 hover:text-sky-500">Scale With Search</a></p>
      </div>
    </div>
  </footer>


  <script>
    // Theme
    if (localStorage.theme === 'light') {
      document.documentElement.classList.remove('dark');
    } else if (localStorage.theme === 'dark' || !('theme' in localStorage)) {
      document.documentElement.classList.add('dark');
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
      document.documentElement.classList.add('dark');
    }

    // Mega menu
    (function() {
      const triggers = document.querySelectorAll('.mega-trigger');
      const panels = document.querySelectorAll('.mega-panel');
      let activePanel = null;
      let closeTimeout = null;

      function openPanel(id) {
        clearTimeout(closeTimeout);
        panels.forEach(p => { p.classList.add('hidden'); });
        triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        const panel = document.getElementById('mega-' + id);
        const trigger = document.querySelector('[data-mega="' + id + '"] .mega-trigger');
        if (panel) { panel.classList.remove('hidden'); activePanel = panel; }
        if (trigger) trigger.setAttribute('aria-expanded', 'true');
      }

      function scheduleClose() {
        closeTimeout = setTimeout(() => {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
          activePanel = null;
        }, 200);
      }

      function cancelClose() { clearTimeout(closeTimeout); }

      triggers.forEach(btn => {
        const wrapper = btn.closest('[data-mega]');
        const id = wrapper.getAttribute('data-mega');
        btn.addEventListener('mouseenter', () => openPanel(id));
        btn.addEventListener('click', (e) => {
          e.preventDefault();
          const panel = document.getElementById('mega-' + id);
          if (panel && !panel.classList.contains('hidden')) {
            panel.classList.add('hidden');
            btn.setAttribute('aria-expanded', 'false');
          } else {
            openPanel(id);
          }
        });
        wrapper.addEventListener('mouseleave', scheduleClose);
      });

      panels.forEach(panel => {
        panel.addEventListener('mouseenter', cancelClose);
        panel.addEventListener('mouseleave', scheduleClose);
      });

      document.addEventListener('click', (e) => {
        if (!e.target.closest('[data-mega]') && !e.target.closest('.mega-panel')) {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });

      document.addEventListener('keydown', (e) => {
        if (e.key === 'Escape') {
          panels.forEach(p => p.classList.add('hidden'));
          triggers.forEach(t => t.setAttribute('aria-expanded', 'false'));
        }
      });
    })();

    // Mobile menu
    const mobileMenuBtn = document.getElementById('mobile-menu-btn');
    const mobileMenu = document.getElementById('mobile-menu');
    const menuIcon = document.getElementById('menu-icon');
    const closeIcon = document.getElementById('close-icon');
    if (mobileMenuBtn) {
      mobileMenuBtn.addEventListener('click', () => {
        mobileMenu.classList.toggle('hidden');
        menuIcon.classList.toggle('hidden');
        closeIcon.classList.toggle('hidden');
      });
    }

    // Mobile accordion sections
    document.querySelectorAll('.mobile-section-toggle').forEach(btn => {
      btn.addEventListener('click', () => {
        const section = btn.nextElementSibling;
        const chevron = btn.querySelector('svg');
        section.classList.toggle('hidden');
        chevron.style.transform = section.classList.contains('hidden') ? '' : 'rotate(180deg)';
      });
    });
  </script>
</body>
</html>